Headquartered in Cupertino, California, Aemetis is a renewable natural gas, renewable fuel and bioproducts company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. Founded in 2006, Aemetis has completed Phase 1 and is expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas (RNG). Aemetis owns and operates a 65 million gallon per year ethanol production facility in California's Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis also owns and operates a 50 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is developing the Carbon Zero biorefinery in Riverbank, California to convert renewable hydrogen from waste orchard wood and renewable electricity from solar and hydroelectric sources combined with non-edible oils into renewable jet fuel and renewable diesel, while pre-extracting cellulosic sugars for use by the Keyes ethanol plant to produce cellulosic ethanol. Aemetis holds a portfolio of patents and related technology licenses for the production of renewable fuels and bioproducts.

Company profile
Ticker
AMTX
Exchange
Website
CEO
Eric McAfee
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AE Biofuels, Inc., AE BIOFUELS, INC., MARWICH II LTD
SEC CIK
Corporate docs
Subsidiaries
Biofuels Marketing, Inc. • Aemetis Biochemicals, Inc. • Aemetis Advanced Products Keyes, Inc. • Aemetis Riverbank, Inc. • Aemetis Advanced Products Riverbank, Inc. • Aemetis Properties Riverbank, Inc. • Aemetis Health Products, Inc. • Aemetis Carbon Capture, Inc. • Aemetis International, Inc. • International Biofuels Ltd ...
IRS number
261407544
AMTX stock data
News

Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022
9 Aug 22
U.S. Stock Futures Edge Higher; Crude Oil Drops
9 Aug 22
Truist Securities Downgrades Aemetis to Hold, Announces $12 Price Target
9 Aug 22
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
8 Aug 22
Nasdaq Falls Over 100 Points, Marker Therapeutics Shares Spike Higher
5 Aug 22
Press releases
Aemetis Reports Second Quarter 2022 Financial Results
4 Aug 22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aemetis, Inc. - AMTX
1 Aug 22
Aemetis to Review Second Quarter 2022 Financial Results on August 4, 2022
1 Aug 22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aemetis, Inc. - AMTX
21 Jul 22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aemetis, Inc. - AMTX
13 Jul 22
Analyst ratings and price targets
Current price
Average target
$19.50
Low target
$12.00
High target
$27.00
Truist Securities
Downgraded
$12.00
Credit Suisse
Maintains
$27.00
Investment data
Securities sold
Number of investors
Calendar
8 Aug 22
12 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M |
Cash burn (monthly) | 637.67K | 301.42K | 2.56M | (no burn) | (no burn) | 743.08K |
Cash used (since last report) | 928.05K | 438.68K | 3.73M | n/a | n/a | 1.08M |
Cash remaining | 2.63M | 3.12M | -170.7K | n/a | n/a | 2.48M |
Runway (months of cash) | 4.1 | 10.3 | -0.1 | n/a | n/a | 3.3 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Mar 22 | Block John R | Common Stock | Sell | Acquire S | No | No | 12.1172 | 10,371 | 125.67K | 24,091 |
14 Mar 22 | Block John R | Common Stock | Sell | Dispose S | No | No | 12.1172 | 18,865 | 228.59K | 34,462 |
14 Mar 22 | Block John R | Common Stock | Sell | Dispose S | No | No | 12.1172 | 1,300 | 15.75K | 53,327 |
14 Mar 22 | Block John R | Common Stock | Option exercise | Dispose M | No | No | 1.72 | 35,000 | 60.2K | 89,627 |
14 Mar 22 | Block John R | Common Stock | Sell | Dispose S | No | No | 12.1172 | 35,000 | 424.1K | 54,627 |
14 Mar 22 | Block John R | Option Common stock and Series B Preferred | Option exercise | Dispose M | No | No | 1.72 | 35,000 | 60.2K | 0 |
23 Feb 22 | Barton Francis P | Common Stock | Option exercise | Acquire M | No | No | 0.6 | 60,000 | 36K | 138,452 |
23 Feb 22 | Barton Francis P | Common Stock | Option exercise | Acquire M | No | No | 0.86 | 60,000 | 51.6K | 78,452 |
23 Feb 22 | Barton Francis P | Option Common stock and Series B Preferred | Option exercise | Dispose M | No | No | 0.6 | 60,000 | 36K | 0 |
23 Feb 22 | Barton Francis P | Option Common stock and Series B Preferred | Option exercise | Dispose M | No | No | 0.86 | 60,000 | 51.6K | 0 |
Institutional ownership, Q1 2022
53.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 93 |
Opened positions | 19 |
Closed positions | 21 |
Increased positions | 29 |
Reduced positions | 32 |
13F shares | Current |
---|---|
Total value | 538.42M |
Total shares | 18.65M |
Total puts | 362.8K |
Total calls | 400.8K |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 3.09M | $39.11M |
Alliancebernstein | 2.15M | $27.23M |
STT State Street | 2M | $25.32M |
Grantham, Mayo, Van Otterloo & Co. | 1.88M | $23.88M |
Encompass Capital Advisors | 1.88M | $23.87M |
Vanguard | 1.57M | $19.95M |
MS Morgan Stanley | 612.15K | $7.75M |
Geode Capital Management | 521.19K | $6.6M |
Renaissance Technologies | 415.09K | $5.26M |
Wellington Management | 380.5K | $4.82M |
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AAPR, air, arose, attached, bioeconomy, biofuel, CAL, CARB, certification, circular, conifer, constitute, contemporaneously, copy, created, data, deconstructing, enable, extract, extraction, ferment, fire, Fixed, forecast, forecasted, Forestry, furnished, head, hub, imposing, incurrence, Institute, interconnect, ionic, JBEI, Joint, leading, mile, mission, MMBTU, pathway, pioneering, preliminary, pretreatment, prohibiting, Protair, PUPA, Regulation, rental, reorganization, request, restore, retroactively, route, Sierra, sublessor, taxable, uncollectible, updated, USDA, viable, woody, Workforce, wrote
Removed:
adjusted
Current reports
8-K
Aemetis Reports Second Quarter 2022 Financial Results
4 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 22
8-K
Aemetis Reports First Quarter 2022 Financial Results
12 May 22
8-K
Aemetis Reports 2021 Fourth Quarter and Year-End Results
10 Mar 22
8-K
Entry into a Material Definitive Agreement
4 Mar 22
8-K
Regulation FD Disclosure
28 Feb 22
8-K
Entry into a Material Definitive Agreement
20 Dec 21
8-K
Aemetis, Inc. Reports Third Quarter 2021 Financial Results
12 Nov 21
8-K
Material Modifications to Rights of Security Holders
2 Nov 21
8-K
Regulation FD Disclosure
21 Oct 21
Registration and prospectus
S-8
Registration of securities for employees
10 Mar 22
424B5
Prospectus supplement for primary offering
30 Nov 21
POS AM
Prospectus update (post-effective amendment)
11 Nov 21
8-A12B/A
Registration of securities on exchange (amended)
10 Nov 21
424B5
Prospectus supplement for primary offering
18 Aug 21
S-3
Shelf registration
30 Jul 21
S-8
Registration of securities for employees
15 Mar 21
424B5
Prospectus supplement for primary offering
26 Jan 21
S-8
Registration of securities for employees
1 Oct 20
424B5
Prospectus supplement for primary offering
1 Oct 20
Other
EFFECT
Notice of effectiveness
18 Nov 21
EFFECT
Notice of effectiveness
16 Aug 21
CORRESP
Correspondence with SEC
10 Aug 21
UPLOAD
Letter from SEC
1 Aug 21
EFFECT
Notice of effectiveness
25 Sep 20
CORRESP
Correspondence with SEC
20 Sep 20
UPLOAD
Letter from SEC
3 Sep 20
UPLOAD
Letter from SEC
14 Feb 17
CORRESP
Correspondence with SEC
2 Jan 17
UPLOAD
Letter from SEC
14 Dec 16
Ownership
SC 13G
AEMETIS / BlackRock ownership change
9 May 22
4
AEMETIS / JOHN R BLOCK ownership change
15 Mar 22
4
AEMETIS / FRANCIS P BARTON ownership change
24 Feb 22
4
AEMETIS / Todd Waltz ownership change
24 Feb 22
SC 13G/A
AEMETIS / Encompass Capital Advisors ownership change
14 Feb 22
SC 13G
AEMETIS / ALLIANCEBERNSTEIN ownership change
14 Feb 22
SC 13G/A
AEMETIS / Portolan Capital Management ownership change
11 Feb 22
SC 13G/A
AEMETIS / RENAISSANCE TECHNOLOGIES ownership change
10 Feb 22
SC 13G
AEMETIS / STATE STREET ownership change
9 Feb 22
SC 13G
AEMETIS / BlackRock ownership change
4 Feb 22
Transcripts
2022 Q1
Earnings call transcript
13 May 22
2021 Q4
Earnings call transcript
11 Mar 22
2021 Q3
Earnings call transcript
12 Nov 21
2021 Q2
Earnings call transcript
13 Aug 21
2021 Q1
Earnings call transcript
15 May 21
2020 Q4
Earnings call transcript
12 Mar 21
2020 Q3
Earnings call transcript
12 Nov 20
2020 Q2
Earnings call transcript
13 Aug 20
2020 Q1
Earnings call transcript
14 May 20
2019 Q4
Earnings call transcript
12 Mar 20
Reddit threads
The WSB Trash Bin, Discussion Thread for the Week of August 12, 2022
12 Aug 22
My first 7 months daytrading
28 Jul 22
The WSB Trash Bin, Discussion Thread for the Week of July 08, 2022
8 Jul 22
Thoughts on The future of renewables and Aemetis AMTX? It seems the company has signed many offtake contracts for SAF and RNG that in 2-3 years will generate multiples of their mkt. cap. Wondering if the Third Eye Capital notes are keeping this stonk from booming.
19 Jun 22
Daily Discussion Thread - May 12th, 2022
12 May 22
Daily Discussion Thread - May 11th, 2022
11 May 22
Daily Discussion Thread - May 10th, 2022
10 May 22
Daily Discussion Thread - May 9th, 2022
9 May 22
You guys got any overlooked/unorthodox plays that have gone relatively unnoticed?
13 Mar 22
Daily Discussion Thread - March 10th, 2022
10 Mar 22